Acute Gastrointestinal Graft-vs-Host Disease Is Associated With Increased Enteric Bacterial Bloodstream Infection Density in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients-Reference-Cited by-同舟云学术

Acute Gastrointestinal Graft-vs-Host Disease Is Associated With Increased Enteric Bacterial Bloodstream Infection Density in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients

Published:2015-05-05 Issue:3 Volume:61 Page:350-357
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

Levinson Anya,Pinkney Kerice,Jin Zhezhen,Bhatia Monica,Kung Andrew L.,Foca Marc D.,George Diane,Garvin James H.,Sosna Jean,Karamehmet Esra,Robinson Chalitha,Satwani Prakash

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/61/3/350/1325226/civ285.pdf

Reference21 articles.

1. Bacteremia in Blood or Marrow Transplantation Patients: Clinical Risk Factors for Infection and Emerging Antibiotic Resistance

2. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated

3. The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells

4. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins

5. Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review;Pediatric Hematology and Oncology;2024-07-08

2. Prior cytomegalovirus reactivation may lead to worse bacterial bloodstream infection outcomes in HSCT patients;Transplant Immunology;2024-06

3. Epidemiology, Microbiology, and Risk Factors of Bacterial Bloodstream Infections in Patients After Allogeneic Hematopoietic Stem Cell Transplantation;Infection and Drug Resistance;2024-04

4. Epidemiology of bloodstream infections and the impact of antimicrobial resistance in pediatric hematopoietic cell transplant;Transplant Infectious Disease;2024-01-05

5. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease;Blood Advances;2023-09-12